AAAAAA
Results: 26-39/39
Authors:
Catalona, WJ
Citation: Wj. Catalona, The postal service and cancer screening, N ENG J MED, 341(7), 1999, pp. 542-542
Authors:
Ramos, CG
Carvahal, GF
Mager, DE
Haberer, B
Catalona, WJ
Citation: Cg. Ramos et al., The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels, J UROL, 162(5), 1999, pp. 1587-1590
Authors:
Southwick, PC
Catalona, WJ
Partin, AW
Slawin, KM
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Parson, RE
Loveland, KG
Citation: Pc. Southwick et al., Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial, J UROL, 162(4), 1999, pp. 1346-1351
Authors:
Catalona, WJ
Carvalhal, GF
Mager, DE
Smith, DS
Citation: Wj. Catalona et al., Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies, J UROL, 162(2), 1999, pp. 433-438
Authors:
Olsson, CA
Catalona, WJ
Citation: Ca. Olsson et Wj. Catalona, Questions and responses, J UROL, 162(2), 1999, pp. 438-438
Authors:
Carvalhal, GF
Smith, DS
Ramos, C
Krygiel, J
Mager, DE
Yan, Y
Catalona, WJ
Citation: Gf. Carvalhal et al., Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening, J UROL, 162(1), 1999, pp. 113-118
Authors:
Ramos, CG
Carvalhal, GF
Smith, DS
Mager, DE
Catalona, WJ
Citation: Cg. Ramos et al., Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer, J UROL, 161(5), 1999, pp. 1525-1529
Authors:
Ramos, CG
Carvalhal, GF
Smith, DS
Mager, DE
Catalona, WJ
Citation: Cg. Ramos et al., Retrospective comparison of radical retropubic prostatectomy and (125)iodine brachytherapy for localized prostate cancer, J UROL, 161(4), 1999, pp. 1212-1215
Authors:
Catalona, WJ
Citation: Wj. Catalona, Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison - Comment, J UROL, 161(4), 1999, pp. 1227-1227
Authors:
Carvalhal, GF
Smith, DS
Mager, DE
Ramos, C
Catalona, WJ
Citation: Gf. Carvalhal et al., Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng/ml or less, J UROL, 161(3), 1999, pp. 835-839
Authors:
Catalona, WJ
Citation: Wj. Catalona, Refined testing and targeted therapy lead new fight against prostate cancer, GERIATRICS, 54(9), 1999, pp. 49-54
Authors:
Magklara, A
Scorilas, A
Catalona, WJ
Diamandis, EP
Citation: A. Magklara et al., The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA, CLIN CHEM, 45(11), 1999, pp. 1960-1966
Authors:
Catalona, WJ
Ramos, CG
Carvalhal, GF
Citation: Wj. Catalona et al., Contemporary results of anatomic radical prostatectomy, CA-A CANC J, 49(5), 1999, pp. 282-296
Authors:
Monk, TG
Goodnough, LT
Brecher, ME
Colberg, JW
Andriole, GL
Catalona, WJ
Citation: Tg. Monk et al., A prospective randomized comparison of three blood conservation strategiesfor radical prostatectomy, ANESTHESIOL, 91(1), 1999, pp. 24-33